These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14104834)

  • 21. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 22. OFFICE MANAGEMENT OF THE ANTICOAGULATED PATIENT.
    UDALL JA
    Geriatrics; 1964 Jul; 19():505-10. PubMed ID: 14183246
    [No Abstract]   [Full Text] [Related]  

  • 23. SELF THROMBOPLASTIN-PROTHROMBIN TIME. A NEW TEST IN HEMORRHAGIC SYNDROMES AND IN THE CONTROL OF ANTICOAGULANT THERAPY.
    BERKARDA B; DERMAN U
    Thromb Diath Haemorrh; 1964 Jul; 11():468-75. PubMed ID: 14191724
    [No Abstract]   [Full Text] [Related]  

  • 24. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
    FRANCESCON M; BUTTO M
    Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951
    [No Abstract]   [Full Text] [Related]  

  • 25. THE LABORATORY CONTROL OF ANTICOAGULANT THERAPY. QUICK'S ONE-STAGE PROTHROMBIN TIME COMPARED WITH THROMBOTEST.
    COUNIHAN TB; FARRELL I; KEELAN P
    Ir J Med Sci; 1964 Jan; 457():31-6. PubMed ID: 14113901
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STANDARDIZATION OF LABORATORY CONTROL OF ORAL LONG TERM ANTICOAGULANT THERAPY.
    ROBICHAUX EB
    Vasc Dis; 1965 Jan; 2():34-8. PubMed ID: 14252942
    [No Abstract]   [Full Text] [Related]  

  • 28. [SOME PROBLEMS OF THE ANTICOAGULANT TREATMENT OF DEEP VENOUS THROMBOSIS IN PREGNANCY].
    FORGACS J; NEMETH L
    Orv Hetil; 1964 Jun; 105():1162-5. PubMed ID: 14160767
    [No Abstract]   [Full Text] [Related]  

  • 29. [Report on the experience with long-term anticoagulant treatment].
    Egli H
    Thromb Diath Haemorrh Suppl; 1964; 12():89-92. PubMed ID: 5882983
    [No Abstract]   [Full Text] [Related]  

  • 30. ANTICOAGULANT THERAPY TODAY.
    VIGRAN IM
    Angiology; 1964 Jan; 15():1-10. PubMed ID: 14106728
    [No Abstract]   [Full Text] [Related]  

  • 31. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 32. HAEMATURIA AND ANTICOAGULANTS.
    REILLY EB; PERRY A; FUJITA K; NAKAMURA RM
    Lancet; 1964 Mar; 1(7332):554. PubMed ID: 14100201
    [No Abstract]   [Full Text] [Related]  

  • 33. ACCIDENTAL HEPARIN POISONING IN AN INFANT.
    PACHMAN DJ
    Am J Dis Child; 1965 Aug; 110():210-2. PubMed ID: 14320776
    [No Abstract]   [Full Text] [Related]  

  • 34. CONTROL OF ANTICOAGULANT THERAPY BY THROMBOTEST METHOD.
    KEYSER JW
    Br Med J; 1963 Dec; 2(5371):1514-6. PubMed ID: 14063080
    [No Abstract]   [Full Text] [Related]  

  • 35. [USE IN CARDIOLOGY OF A NEW ANTICOAGULANT: DICOUMOXYL (1-BIS-METHOXY (4-HYDROXY, 3-COUMARINYL) 2,2-ETHANE). APROPOS OF 29 CASES].
    MERIEL P; GALINIER F; BOUNHOURE JP; GAVALDA J
    Toulouse Med; 1964; 65():849-58. PubMed ID: 14204295
    [No Abstract]   [Full Text] [Related]  

  • 36. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 37. COAGULATION TESTS IN ANTICOAGULANT THERAPY.
    DAVIES DW
    Med J Aust; 1965 Jan; 1(5):150-4. PubMed ID: 14247940
    [No Abstract]   [Full Text] [Related]  

  • 38. [A NEW CONTROL METHOD FOR ANTICOAGULANT THERAPY].
    BERKARDA B; DERMAN U
    Turk Tip Cemiy Mecm; 1963 Oct; 29():569-74. PubMed ID: 14096257
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 40. THE LIMITATIONS OF HEPARIN THERAPY AFTER ARTERIAL RECONSTRUCTION.
    SALZMAN EW
    Surgery; 1965 Jan; 57():131-8. PubMed ID: 14242040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.